FREE Account Opening + No Clearing Fees
Loading...

Interiors and More IPO vs Zenith Drugs IPO

Comparision between Interiors and More IPO and Zenith Drugs IPO.

IPO Details

Interiors and More IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Zenith Drugs IPO is a SME Book Built Issue proposed to list at NSE SME.

  Interiors and More IPO Zenith Drugs IPO
Logo Interiors and More IPO Logo Zenith Drugs IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Book Built Issue Book Built Issue
Listing At NSE SME NSE SME
Lead Managers Gretex Corporate Services Limited Gretex Corporate Services Limited
Registrar Bigshare Services Pvt Ltd Bigshare Services Pvt Ltd
Market Maker Gretex Share Broking Private Limited Gretex Share Broking Private Limited
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor Anchor Investor Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Interiors and More IPO is up to ₹42.00 Cr whereas the issue size of the Zenith Drugs IPO is up to ₹40.68 Cr. The final issue price of Interiors and More IPO is ₹227.00 per share and of Zenith Drugs IPO is ₹79.00 per share.

  Interiors and More IPO Zenith Drugs IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹216.00 per share ₹75.00 per share
Issue Price (Upper) ₹227.00 per share ₹79.00 per share
Issue Price (Final) ₹227.00 per share ₹79.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 600 shares 1600 shares
Fresh Issue Size 18,50,400 shares 51,48,800 shares
Fresh Issue Size (Amount) up to ₹42.00 Cr up to ₹40.68 Cr
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 18,50,400 shares 51,48,800 shares
Issue Size Total (Amount) up to ₹42.00 Cr up to ₹40.68 Cr

IPO Timetable

Interiors and More IPO opens on Feb 15, 2024, while Zenith Drugs IPO opens on Feb 19, 2024. The closing date of Interiors and More IPO and Zenith Drugs IPO is Feb 20, 2024, and Feb 22, 2024, respectively.

  Interiors and More IPO Zenith Drugs IPO
Anchor Bid Date Feb 14, 2024 Feb 16, 2024
Issue Open Feb 15, 2024 Feb 19, 2024
Issue Close Feb 20, 2024 Feb 22, 2024
Basis Of Allotment (Tentative) Feb 21, 2024 Feb 23, 2024
Initiation of Refunds (Tentative) Feb 22, 2024 Feb 26, 2024
Credit of Share (Tentative) Feb 22, 2024 Feb 26, 2024
Listing date (Tentative) Feb 23, 2024 Feb 27, 2024
Anchor Lockin End date 1 Mar 22, 2024 Mar 24, 2024
Anchor Lockin End date 2 May 21, 2024 May 23, 2024

Financials

Interiors and More IPO P/E ratio is 19.7, as compared to Zenith Drugs IPO P/E ratio of 18.4.

  Interiors and More IPO Zenith Drugs IPO
Financial

Interiors and More Limited Financial Information (Restated)

Interiors and More Limited's revenue increased by 153.09% and profit after tax (PAT) rose by 467.64% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended31 Dec 202331 Mar 202331 Mar 202231 Mar 2021
Assets3,722.593,094.631,952.131,478.30
Revenue1,853.782,527.17998.53663.10
Profit After Tax354.57592.84104.4443.33
Net Worth1,349.78995.21405.07300.63
Reserves and Surplus835.28823.71233.57129.13
Total Borrowing1,645.861,439.771,297.33904.02
Amount in ₹ Lakhs

Zenith Drugs Limited Financial Information (Restated Consolidated)

Zenith Drugs Limited's revenue increased by 24.85% and profit after tax (PAT) rose by 64.7% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended30 Sep 202331 Mar 202331 Mar 2022
Assets11,249.049,793.836,858.47
Revenue6,948.4311,569.659,266.63
Profit After Tax539.38515.29312.86
Net Worth2,264.961,724.421,209.09
Reserves and Surplus1,064.961,684.421,169.09
Total Borrowing2,902.812,605.031,880.86
Amount in ₹ Lakhs
Promoter Shareholding (Pre-Issue) 95.08% 100.00%
Promoter Shareholding (Post-Issue) 69.93% 69.98%
P/E Ratio 19.7 18.4
Market Cap ₹158.80 Cr. ₹135.48 Cr.
ROE 84.68%% 35.13%%
ROCE 75.58%% 37.29%%
Debt/Equity 1.45 1.51
EPS ₹11.52 ₹4.29
RoNW 59.57%% 29.88%%

Shares Offered

In the Interiors and More IPO retail investors (RII) are offered 6,15,600 shares while in Zenith Drugs IPO retail investors are offered 6,15,600 shares. Qualified institutional buyers (QIB) are offered 3,51,600 shares in Interiors and More IPO and 8,59,200 shares in Zenith Drugs IPO.

  Interiors and More IPO Zenith Drugs IPO
Anchor Investor Reserveration 5,26,200 shares 12,88,000 shares
Market Maker Reserveration 93,000 shares 8,52,800 shares
QIB 3,51,600 shares 8,59,200 shares
NII 2,64,000 shares 6,44,800 shares
RII 6,15,600 shares 15,04,000 shares
Employee 0 shares 0 shares
Others
Total 12,31,200 shares 30,08,000 shares

Bids Received (Subscription)

Interiors and More IPO subscribed 11.22x in total, whereas Zenith Drugs IPO subscribed 179.18x.

  Interiors and More IPO Zenith Drugs IPO
QIB (times) 3.54x 106.72x
NII (times) 30.32x 368.77x
Big NII (times)
Small NII (times)
RII (times) 7.41x 139.28x
Employee (times)
Other (times)
Total (times) 11.22x 179.18x

Comments

Add a public comment...